Len Lichtenfeld MD MACP emphasizes the urgent need for new colorectal cancer (CRC) screening options in his latest article for Healthcare Innovation . As we strive for improved patient outcomes and accessibility, exploring innovative approaches is essential. Read more of this important perspective.
Guardant Health’s Post
More Relevant Posts
-
Did you know that 1 in 3 Americans are not up to date on their CRC screening? 1 IN 3! (50,000,000 people) THAT IS INSANE! Colorectal cancer is 100% preventable if detected early. If I can tell you one thing, it is GET SCREENED! I don't care how healthy you are, or how much you work out, cancer does not discriminate! Here are some CRC FACTS - if I need to give you another reason to talk to your doctor about screening: **Of all cancers, colorectal cancer will take the most lives of people under 50 by 2030. (Believe it or not, 2030 is only 5 1/2 years away.) - The incidence of early-age onset CRC — diagnoses under age 50 — is expected to increase by more than 140% by 2030. - More than 27,000 people under age 50 will be diagnosed with colorectal cancer in 2030. - Among adults under 50, colorectal cancer is now the #1 cause of cancer death in men and the #2 cause in women. This is a change from its 4th place ranking in 1998. - The number of patients in the U.S. diagnosed under 55 years of age doubled from 11% in 1995 to 20% in 2019. I am sharing all this info to say, there is NO reason to be scared or worried about getting screened. It can save your life! Guardant Health now has a new option where routine bloodwork can detect if you need a colonoscopy! Read this article. Incredible news!
Len Lichtenfeld MD MACP emphasizes the urgent need for new colorectal cancer (CRC) screening options in his latest article for Healthcare Innovation . As we strive for improved patient outcomes and accessibility, exploring innovative approaches is essential. Read more of this important perspective.
It’s Time for a New Option in Colorectal Cancer Screening
hcinnovationgroup.com
To view or add a comment, sign in
-
New findings from CALGB/SWOG 80405: High HER2 expression in metastatic colorectal cancer significantly predicts longer progression-free and overall survival, influencing decision-making on bevacizumab vs cetuximab treatment. #CancerResearch #PrecisionMedicine #HealthcareInnovation
To view or add a comment, sign in
-
-
Mainz Biomed unveils consolidated findings from both ColoFuture and eAArly DETECT study. 92% sensitivity for Colorectal Cancer seems remarkable The study underscored the substantial advantage of the multimodal screening test compared to existing methods, especially in identifying advanced precancerous lesions. Notably, the sensitivity for detecting high-grade dysplasia, which carries a heightened risk of progressing to cancer, with the multimodal approach was 95.8%, markedly surpassing other non-invasive tests presently accessible. Unlock Expert Insights and In-Depth Analysis Exclusively with DelveInsight Business Research LLP at American Society of Clinical Oncology (ASCO) 2024 @ https://lnkd.in/guN-Vb79 #asco24 #asco #ascoconference #MainzBiomedFindings #ColoFutureStudy #eAArlyDETECT #ColorectalCancerScreening #MultimodalScreeningTest #CRCSensitivity #AdvancedPrecancerousLesions #HighGradeDysplasia #NonInvasiveTests #CancerPrevention #EarlyDetection #InnovativeDiagnostics #HealthcareAdvancements #ScreeningEffectiveness #BiomedicalResearch
ColoFuture and eAArly DETECT Studies | ASCO 2024
delveinsight.com
To view or add a comment, sign in
-
Hear from subject matter experts Aasma Shaukat, MD, MPH, and Erin Peterson from the Colon Cancer Coalition as they address how to capture patient compliance for colorectal cancer screenings, gain early detection and improve patient outcomes. Watch now. #ColorectalCancer
Colorectal cancer: How to increase screening compliance rates
learn-more.com
To view or add a comment, sign in
-
Hear from subject matter experts Aasma Shaukat, MD, MPH, and Erin Peterson from the Colon Cancer Coalition as they address how to capture patient compliance for colorectal cancer screenings, gain early detection and improve patient outcomes. Watch now. #ColorectalCancer
Colorectal cancer: How to increase screening compliance rates
learn-more.com
To view or add a comment, sign in
-
Hear from subject matter experts Aasma Shaukat, MD, MPH, and Erin Peterson from the Colon Cancer Coalition as they address how to capture patient compliance for colorectal cancer screenings, gain early detection and improve patient outcomes. Watch now. #ColorectalCancer
Colorectal cancer: How to increase screening compliance rates
learn-more.com
To view or add a comment, sign in
-
Hear from subject matter experts Aasma Shaukat, MD, MPH, and Erin Peterson from the Colon Cancer Coalition as they address how to capture patient compliance for colorectal cancer screenings, gain early detection and improve patient outcomes. Watch now. #ColorectalCancer
Colorectal cancer: How to increase screening compliance rates
learn-more.com
To view or add a comment, sign in
-
Hear from subject matter experts Aasma Shaukat, MD, MPH, and Erin Peterson from the Colon Cancer Coalition as they address how to capture patient compliance for colorectal cancer screenings, gain early detection and improve patient outcomes. Watch now. #ColorectalCancer
Colorectal cancer: How to increase screening compliance rates
learn-more.com
To view or add a comment, sign in
-
Hear from subject matter experts Aasma Shaukat, MD, MPH, and Erin Peterson from the Colon Cancer Coalition as they address how to capture patient compliance for colorectal cancer screenings, gain early detection and improve patient outcomes. Watch now. #ColorectalCancer
Colorectal cancer: How to increase screening compliance rates
learn-more.com
To view or add a comment, sign in
-
Prostate cancer is the second most common cancer among men. Early detection is key! Schedule your digital rectal exam and PSA test at Acouns Laboratory today and prioritize your health
To view or add a comment, sign in
-
Sales Manager at Eris Lifesciences
1moInteresting!